
Dolby Laboratories reported its Q4 earnings with a revenue of $304.81 million, slightly below the estimated $307.9 million. However, the company beat the earnings per share (EPS) estimate, reporting an adjusted EPS of $0.81 compared to the expected $0.70. The positive earnings report and a strong forecast for 2025 have resulted in a surge in Dolby's shares, which rose by 9.7% post-market to $77.80 and an additional 12.7% pre-market. The company expects non-GAAP earnings for the first fiscal quarter of 2025 to be between $0.96 and $1.11, with revenue ranging from $330 million to $360 million. Licensing revenue is projected to be between $305 million and $335 million. Dolby's recent acquisition of GE Licensing has boosted its imaging patents, and partnerships with Meta and Apple are driving growth. Net income for the quarter was $59 million.
$DLB Dolby Laboratories Q4 adj. EPS 0.81 (exp. 0.70) revenue USD 305mln (exp. 307.9mln)
$DLB (+12.7% pre) Dolby Laboratories Reports Q4 Earnings, Provides Strong Forecast For 2025, Shares Surge - BZ https://t.co/J4QX6DkDwy
Dolby Laboratories, $DLB, Q4 & FY24 Results: 🟢 +9.7% Post-Market ($77.80) 📊 Adj EPS: $0.81 🟢 💰 Revenue: $304.81M 🟢 📈 Net Income: $59M 🔍 Dolby's GE Licensing acquisition boosts imaging patents, and partnerships with Meta and Apple drive growth. https://t.co/NVLMxeJEpm
